BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 21720262)

  • 21. [Therapy of heart failure with beta-blockers?].
    Osterziel KJ; Dietz R
    Z Kardiol; 1997 Jan; 86(1):1-8. PubMed ID: 9133118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Introduction of metoprolol increases plasma B-type cardiac natriuretic peptides in mild, stable heart failure.
    Davis ME; Richards AM; Nicholls MG; Yandle TG; Frampton CM; Troughton RW
    Circulation; 2006 Feb; 113(7):977-85. PubMed ID: 16476851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The acute effect of Metoprolol upon NT-proBNP level in patients with congestive heart failure.
    Zdrenghea D; Pop D; Ilea M; Bodisz G; Mălai A; Zdrenghea M
    Rom J Intern Med; 2009; 47(1):35-40. PubMed ID: 19886067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microvascular tissue perfusion is impaired in acutely decompensated heart failure and improves following standard treatment.
    Lauten A; Ferrari M; Goebel B; Rademacher W; Schumm J; Uth O; Kiehntopf M; Figulla HR; Jung C
    Eur J Heart Fail; 2011 Jul; 13(7):711-7. PubMed ID: 21543374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional improvement in heart failure patients treated with beta-blockers is associated with a decline of cytokine levels.
    Mayer B; Holmer SR; Hengstenberg C; Lieb W; Pfeifer M; Schunkert H
    Int J Cardiol; 2005 Aug; 103(2):182-6. PubMed ID: 16080978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of selective angiotensin II and beta1-receptor blockade on renal haemodynamics and sodium handling during orthostatic stress in healthy individuals.
    Wuerzner G; Burnier M
    J Hypertens Suppl; 2006 Mar; 24(1):S89-93. PubMed ID: 16601579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Does chronic oral treatment with beta-receptor blockers have an effect on positive inotropic therapy of coronary patients with adrenaline after extracorporeal circulation?].
    Günnicker M; Brinkmann M; Freund U; Piotrowski J; Schieffer M; Velser U
    Herz; 1995 Dec; 20(6):399-411. PubMed ID: 8582699
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of dopamine on renal haemodynamics tubular function and sodium excretion in normal humans.
    Olsen NV
    Dan Med Bull; 1998 Jun; 45(3):282-97. PubMed ID: 9675540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beta-blockers restore calcium release channel function and improve cardiac muscle performance in human heart failure.
    Reiken S; Wehrens XH; Vest JA; Barbone A; Klotz S; Mancini D; Burkhoff D; Marks AR
    Circulation; 2003 May; 107(19):2459-66. PubMed ID: 12743001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improvement of left ventricular diastolic function induced by β-blockade: a comparison between nebivolol and metoprolol.
    Fang Y; Nicol L; Harouki N; Monteil C; Wecker D; Debunne M; Bauer F; Lallemand F; Richard V; Thuillez C; Mulder P
    J Mol Cell Cardiol; 2011 Aug; 51(2):168-76. PubMed ID: 21640121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The calcium channel blocker felodipine attenuates the positive hemodynamic effects of the beta-blocker metoprolol in severe dilated cardiomyopathy--a prospective, randomized, double-blind and placebo-controlled study with invasive hemodynamic assessment.
    Braun M; Edelmann F; Knapp M; Schön S; Schwencke C; Simonis G; Borst M; Weinbrenner C; Strasser RH
    Int J Cardiol; 2009 Feb; 132(2):248-56. PubMed ID: 18579230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Improved kidney function with intravenous prostaglandin E1 in patients with terminal heart failure].
    Wutte M; Hülsmann M; Berger R; Rödler S; Frey B; Stanek B; Pacher R
    Wien Klin Wochenschr; 1998 Jul; 110(13-14):473-8. PubMed ID: 9746960
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.
    Mitrovic V; Seferovic P; Dodic S; Krotin M; Neskovic A; Dickstein K; de Voogd H; Böcker C; Ziegler D; Godes M; Nakov R; Essers H; Verboom C; Hocher B
    Circ Heart Fail; 2009 Nov; 2(6):523-31. PubMed ID: 19919976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beta blockade in congestive heart failure: persistent adverse haemodynamic effects during chronic treatment with subsequent doses.
    Kukin ML; Kalman J; Mannino MM; Buchholz-Varley C; Ocampo O
    Heart; 1997 Nov; 78(5):444-9. PubMed ID: 9415001
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute effects of urocortin 2 on cardiac function and propensity for arrhythmias in an animal model of hypertension-induced left ventricular hypertrophy and heart failure.
    Meili-Butz S; Bühler K; John D; Buser P; Vale WW; Peterson KL; Brink M; Dieterle T
    Eur J Heart Fail; 2010 Aug; 12(8):797-804. PubMed ID: 20388649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined alpha-beta blockade (doxazosin plus metoprolol) compared with beta blockade alone in chronic congestive heart failure.
    Kukin ML; Kalman J; Mannino M; Freudenberger R; Buchholz C; Ocampo O
    Am J Cardiol; 1996 Mar; 77(7):486-91. PubMed ID: 8629589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Haemodynamic, endocrine and renal actions of adrenomedullin 5 in an ovine model of heart failure.
    Rademaker MT; Charles CJ; Nicholls MG; Richards AM
    Clin Sci (Lond); 2012 May; 122(9):429-37. PubMed ID: 22087608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hemodynamic, hormonal, and renal effects of (pro)renin receptor blockade in experimental heart failure.
    Rademaker MT; Yandle TG; Ellmers LJ; Charles CJ; Nicholls MG; Richards AM
    Circ Heart Fail; 2012 Sep; 5(5):645-52. PubMed ID: 22798523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative pharmacokinetics and pharmacodynamics of urocortins 1, 2 and 3 in healthy sheep.
    Patel K; Rademaker MT; Kirkpatrick CM; Charles CJ; Fisher S; Yandle TG; Richards AM
    Br J Pharmacol; 2012 Jul; 166(6):1916-25. PubMed ID: 22339174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of vasoactive peptide urocortin 2 on hemodynamics in spontaneous hypertensive rat and the role of L-type calcium channel and CRFR2.
    Liu C; Liu X; Yang J; Duan Y; Yao H; Li F; Zhang X
    Pharmacol Rep; 2015 Apr; 67(2):394-8. PubMed ID: 25712670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.